Regeneration of the articular surface of the rabbit synovial joint by cell homing: A proof of concept study

Columbia University Medical Center, Tissue Engineering and Regenerative Medicine Laboratory, New York, NY 10032, USA.
The Lancet (Impact Factor: 45.22). 08/2010; 376(9739):440-8. DOI: 10.1016/S0140-6736(10)60668-X
Source: PubMed


A common approach for tissue regeneration is cell delivery, for example by direct transplantation of stem or progenitor cells. An alternative, by recruitment of endogenous cells, needs experimental evidence. We tested the hypothesis that the articular surface of the synovial joint can regenerate with a biological cue spatially embedded in an anatomically correct bioscaffold.
In this proof of concept study, the surface morphology of a rabbit proximal humeral joint was captured with laser scanning and reconstructed by computer-aided design. We fabricated an anatomically correct bioscaffold using a composite of poly-epsilon-caprolactone and hydroxyapatite. The entire articular surface of unilateral proximal humeral condyles of skeletally mature rabbits was surgically excised and replaced with bioscaffolds spatially infused with transforming growth factor beta3 (TGFbeta3)-adsorbed or TGFbeta3-free collagen hydrogel. Locomotion and weightbearing were assessed 1-2, 3-4, and 5-8 weeks after surgery. At 4 months, regenerated cartilage samples were retrieved from in vivo and assessed for surface fissure, thickness, density, chondrocyte numbers, collagen type II and aggrecan, and mechanical properties.
Ten rabbits received TGFbeta3-infused bioscaffolds, ten received TGFbeta3-free bioscaffolds, and three rabbits underwent humeral-head excision without bioscaffold replacement. All animals in the TGFbeta3-delivery group fully resumed weightbearing and locomotion 3-4 weeks after surgery, more consistently than those in the TGFbeta3-free group. Defect-only rabbits limped at all times. 4 months after surgery, TGFbeta3-infused bioscaffolds were fully covered with hyaline cartilage in the articular surface. TGFbeta3-free bioscaffolds had only isolated cartilage formation, and no cartilage formation occurred in defect-only rabbits. TGFbeta3 delivery yielded uniformly distributed chondrocytes in a matrix with collagen type II and aggrecan and had significantly greater thickness (p=0.044) and density (p<0.0001) than did cartilage formed without TGFbeta3. Compressive and shear properties of TGFbeta3-mediated articular cartilage did not differ from those of native articular cartilage, and were significantly greater than those of cartilage formed without TGFbeta3. Regenerated cartilage was avascular and integrated with regenerated subchondral bone that had well defined blood vessels. TGFbeta3 delivery recruited roughly 130% more cells in the regenerated articular cartilage than did spontaneous cell migration without TGFbeta3.
Our findings suggest that the entire articular surface of the synovial joint can regenerate without cell transplantation. Regeneration of complex tissues is probable by homing of endogenous cells, as exemplified by stratified avascular cartilage and vascularised bone. Whether cell homing acts as an adjunctive or alternative approach of cell delivery for regeneration of tissues with different organisational complexity warrants further investigation.
New York State Stem Cell Science; US National Institutes of Health.

Download full-text


Available from: Chang H Lee, Mar 24, 2014
  • Source
    • "Together with the diffusion of additive manufacturing, a paradigm shift toward computer-aided tissue engineering (CATE) and in silico scaffolds optimization has occurred [2] [16]. This approach has led to the successful fabrication of patient-specific 3D structures for several TE applications, such as bone TE [17] [18], repair of osteochondral defects [19] [20] and lumbar interbody fusion implants [21]. As a further evolution, bioreactor knowhow has been integrated with AM technologies, pursuing the development of highly integrated and automated systems [22]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Advances introduced by additive manufacturing (AM) have significantly improved the control over the microarchitecture of scaffolds for tissue engineering. This has led to the flourishing of research works addressing the optimization of AM scaffolds microarchitecture to optimally trade-off between conflicting requirements (e.g. mechanical stiffness and porosity level). A fascinating trend concerns the integration of AM with other scaffold fabrication methods (i.e. "combined" AM), leading to hybrid architectures with complementary structural features. Although this innovative approach is still at its beginning, significant results have been achieved in terms of improved biological response to the scaffold, especially targeting the regeneration of complex tissues. This review paper reports the state of the art in the field of combined AM, posing the accent on recent trends, challenges, and future perspectives. Copyright © 2015. Published by Elsevier Ltd.
    Acta biomaterialia 06/2015; 24. DOI:10.1016/j.actbio.2015.06.032 · 6.03 Impact Factor
  • Source
    • "TGFß also functions as anti-arthritic[63] [64] and is able to block inflammation in vivo [65]. TGFß3 also stimulated extracellular matrix (ECM) synthesis and has been evaluated in vitro in rabbit models of acute cartilage injury [66] [67] [68]. However, other studies show a negative effect of TGFß on cartilage. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Transforming growth factor beta (TGFb) is a major signalling pathway in joints. This superfamilly is involved in numerous cellular processes in cartilage. Usually, they are considered to favor chondrocyte differentiation and cartilage repair. However, other studies show also deleterious effects of TGFb which may induce hypertrophy. This may be explained at least in part by alteration of TGFb signaling pathways in aging chondrocytes. This review focuses on the functions of TGFb in joints and the regulation of its signaling mediators (receptors, Smads) during aging and osteoarthritis.
    Aging and Disease 12/2014; 5(6):394-405. DOI:10.14336/AD.2014.0500394 · 3.07 Impact Factor
  • Source
    • "In addition, gelatin-based CultiSpher S is also amenable to active remodeling by cells, leading to the degradation of the microcarriers and subsequently the shrinkage of tissues [20] [31]. A tissue engineering method should be adaptable to fabricating diverse tissue replacements [32]. Human body is made of different tissues and organs with a wide range of configurations. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Mass transfer limitation in conventional top-down tissue engineering makes it impossible to fabricate large size viable tissue replacements. In the present study, we aimed at performing a systemic investigation on the assembling process in perfusion culture for fabricating centimeter-scale macrotissues from cell-laden microcarriers following a bottom-up modular approach. Cells (human fibroblasts, human mesenchymal stem cells or HepG2 cells) were seeded onto microcarriers (Cytopore-2 or CultiSpher S) in spinner flasks and cultured for 14 d and subsequently transferred to perfusion chamber for assembling. It was found that growth of different cells on different microcarriers varied and aggregation of cell-laden microcarriers was favored with CultiSpher S. After perfusion culture for 14 d, while all microtissues could assemble into integral macrotissues, macrotissues of HepG2 cells were structrually most inferior and the assembling of cell-laden CultiSpher S led to a significant shrinkage. By designing perfusion chamber and using agar-based templates, tubular, disc and alphabetic letter-shaped macrotissues could be easily fabricated, suggesting template-assisted assembling. Importantly, it was revealed that there existed both optimal perfusion culture time (21 d) and packing condition (1/4 compression) for the assembling of microtissues. This study lays solid foundation for future applications of microtissue assembling technique in tissue engineering.
    Biotechnology Journal 11/2014; 9(11). DOI:10.1002/biot.201400238 · 3.49 Impact Factor
Show more